It may be possible to reduce the severity of COVID-19 symptoms with an inexpensive amino acid that could open up new treatment options for patients. GABA is a natural molecule that is available ...
Zacks Investment Research on MSN
OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data
Shares of Ovid Therapeutics OVID rallied 39.2% primarily driven by the encouraging top-line data readout from an early-stage ...
For many people with schizophrenia, current antipsychotic medications have been far from perfect in curtailing their cognitive symptoms, leaving remission and recovery out of reach. Prior work has led ...
The study assessed OV329 in 68 healthy subjects, comprising 51 individuals receiving active treatment and 17 receiving ...
An expansive biomarker study confirmed OV329 delivered statistically significant inhibition of GABA-AT as measured across multiple metricsOV329 ...
Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new off-the-shelf therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback